ID

13992

Descripción

This is an open-label (all people know the identity of the intervention), multicenter study in genotype 1 chronic HCV infected liver transplant patients who will be treated for 12 weeks with telaprevir 750 mg every 8 hours given in combination with Peg-IFN-alfa-2a and ribavirin followed by 36 weeks of treatment with Peg-IFN-alfa-2a and ribavirin alone. The total treatment duration will be 48 weeks. Safety will be evaluated throughout the study and will include evaluations of adverse events, clinical laboratory tests, electrocardiogram, vital signs, and physical examination. NCT01571583

Palabras clave

Versiones (1)
  1. 21/3/16 21/3/16 -
Titular de derechos de autor

CC BY-NC 3.0

Subido en

21 de marzo de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

VX-950HPC3006 NCT01571583 Graft Donor Pharmacogenomic Informed Consent recording

Inglés

VX-950HPC3006 NCT01571583 Graft Donor Pharmacogenomic Informed Consent recording

1 formularios  
Graft Donor Pharmacogenomic Informed Consent recording
Descripción

Graft Donor Pharmacogenomic Informed Consent recording

Is appropriate consent from graft donor available for Pharmacogenomic sample collection?
Descripción

If yes, please answer the following two questions If no, please submit form and complete PharGen Graft form

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0013018
UMLS CUI [1,2]
C0021430
date graft donor signed informed consent
Descripción

date graft donor signed informed consent

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0011008
UMLS CUI [1,3]
C0029206
is a conclusive IL28B test result available?
Descripción

(either from previous graft donor testing or from a new test result obtained from donor tissue or cells)

Tipo de datos

integer

Alias
UMLS CUI [1]
C1174094
Volver a la parte superior de la página

Similar models

VX-950HPC3006 NCT01571583 Graft Donor Pharmacogenomic Informed Consent recording

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Graft Donor Pharmacogenomic Informed Consent recording
appropriate consent from graft donor
Item
Is appropriate consent from graft donor available for Pharmacogenomic sample collection?
boolean
C0013018 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
date graft donor signed informed consent
Item
date graft donor signed informed consent
date
C0021430 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C0029206 (UMLS CUI [1,3])
Item
is a conclusive IL28B test result available?
integer
C1174094 (UMLS CUI [1])
conclusive IL28B test result
Code List
is a conclusive IL28B test result available?
CL Item
yes, please submit form and complete PharGen Donor form (1)
CL Item
no, please submit form and complete PharGen Graft form (2)
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial